These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27095790)

  • 1. UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015.
    Cresswell F; Waters L; Briggs E; Fox J; Harbottle J; Hawkins D; Murchie M; Radcliffe K; Rafferty P; Rodger A; Fisher M
    Int J STD AIDS; 2016 Aug; 27(9):713-38. PubMed ID: 27095790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011).
    Benn P; Fisher M; Kulasegaram R; ;
    Int J STD AIDS; 2011 Dec; 22(12):695-708. PubMed ID: 22174049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure.
    Fisher M; Benn P; Evans B; Pozniak A; Jones M; Maclean S; Davidson O; Summerside J; Hawkins D;
    Int J STD AIDS; 2006 Feb; 17(2):81-92. PubMed ID: 16464267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the provision of post-exposure prophylaxis for HIV after sexual exposure following introduction of guidelines and publicity campaigns.
    Roedling S; Reeves I; Copas AJ; Beattie A; Edwards SG; Fisher M; Benn P
    Int J STD AIDS; 2008 Apr; 19(4):241-2. PubMed ID: 18482942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK guideline for the use of HIV post-exposure prophylaxis 2021.
    Cresswell F; Asanati K; Bhagani S; Boffito M; Delpech V; Ellis J; Fox J; Furness L; Kingston M; Mansouri M; Samarawickrama A; Smithson K; Sparrowhawk A; Rafferty P; Roper T; Waters L; Rodger A; Gupta N
    HIV Med; 2022 May; 23(5):494-545. PubMed ID: 35166004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-exposure HIV prophylaxis following sexual exposure: a retrospective audit against recent draft BASHH guidance.
    Day S; Mears A; Bond K; Kulasegaram R
    Sex Transm Infect; 2006 Jun; 82(3):236-7. PubMed ID: 16731676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the characteristics of, and clinical outcomes in men who have sex with men prescribed HIV postexposure prophylaxis following sexual exposure (PEPSE) at sexual health clinics in England?
    Mitchell H; Furegato M; Hughes G; Field N; Nardone A
    Sex Transm Infect; 2017 May; 93(3):207-213. PubMed ID: 27884964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the 2011 UK post-exposure prophylaxis for HIV following sexual exposure guidelines: a regional retrospective audit.
    Bennett A; Wainwright E; Lord E; Oduru M; Chen F; Desmond N; Sherrard J; Duncan S
    Int J STD AIDS; 2015 Sep; 26(10):746-8. PubMed ID: 25332226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does dropping day 5 PEP follow-up affect outcomes? An audit of HIV post-exposure prophylaxis at a central London sexual health clinic.
    O'Keeffe C; Nwokolo N; McOwan A; Whitlock G
    Int J STD AIDS; 2015 Jul; 26(8):590-2. PubMed ID: 25122580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-exposure prophylaxis after sexual exposure (PEPSE) awareness in an HIV-positive cohort.
    Joshi M; Basra A; McCormick C; Webb H; Pakianathan M
    Int J STD AIDS; 2014 Jan; 25(1):67-9. PubMed ID: 23970629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre RCT and economic evaluation of a psychological intervention together with a leaflet to reduce risk behaviour amongst men who have sex with men (MSM) prescribed post-exposure prophylaxis for HIV following sexual exposure (PEPSE): a protocol.
    Llewellyn C; Abraham C; Miners A; Smith H; Pollard A; Benn P; Fisher M
    BMC Infect Dis; 2012 Mar; 12():70. PubMed ID: 22440090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-start HIV postexposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacy.
    Fox JM; Lee MJ; Fairhead CL; Ledwaba-Chapman LM; Nori AV; McQuillan O; Wang Y; Clarke A; Menon-Johansson A
    Sex Transm Infect; 2023 Aug; 99(6):367-372. PubMed ID: 36564186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-exposure prophylaxis in the era of pre-exposure prophylaxis.
    Atim M; Girometti N; Hyndman I; McOwan A; Whitlock G;
    HIV Med; 2020 Nov; 21(10):668-670. PubMed ID: 32902098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The awareness of postexposure prophylaxis for HIV infection following sexual exposure in emergency departments in a regional HIV network.
    Rutland E; Sundaram S; Mani R
    Int J STD AIDS; 2010 Sep; 21(9):636-7. PubMed ID: 21097736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in HIV post-exposure prophylaxis following sexual exposure in Brazil (2011-2019).
    Crepalde-Ribeiro K; de Oliveira Costa J; Pearson SA; Silveira MR; Mendes JC; Dos Santos SF; Cruz MA; Braga MDG
    AIDS Behav; 2022 Dec; 26(12):4115-4125. PubMed ID: 35841464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial of a telephone administered brief HIV risk reduction intervention amongst men who have sex with men prescribed post-exposure prophylaxis for HIV after sexual exposure in the UK: Project PEPSE.
    Llewellyn CD; Abraham C; Pollard A; Jones CI; Bremner S; Miners A; Smith H
    PLoS One; 2019; 14(5):e0216855. PubMed ID: 31120898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of HIV PEPSE and Hepatitis B vaccine following the introduction of a SARC.
    Bennett J; Johnson S
    J Forensic Leg Med; 2011 Nov; 18(8):375-9. PubMed ID: 22018170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-exposure prophylaxis for HIV infection.
    Rey D
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):431-42. PubMed ID: 21504400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-exposure prophylaxis for HIV.
    Drug Ther Bull; 2011 Mar; 49(3):30-3; quiz i. PubMed ID: 21367772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in implementing the 2015 BASHH guidelines for the appropriate use of post-exposure prophylaxis for HIV following sexual exposure.
    Khattak MF
    F1000Res; 2016; 5():1313. PubMed ID: 28649362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.